Cognitive Effects of Repetitive Transcranial Magnetic Stimulation in Patients with Neurodegenerative Diseases–Clinician’s Perspective.

ANDERKOVÁ, Ľubomíra and Irena REKTOROVÁ. Cognitive Effects of Repetitive Transcranial Magnetic Stimulation in Patients with Neurodegenerative Diseases–Clinician’s Perspective. Journal of the neurological sciences. Netherlands: Amsterdam : Elsevier, 2014, vol. 339, 1-2, p. 15-25. ISSN 0022-510X. Available from: https://dx.doi.org/10.1016/j.jns.2014.01.037.

Basic information

• Original name: Cognitive Effects of Repetitive Transcranial Magnetic Stimulation in Patients with Neurodegenerative Diseases–Clinician’s Perspective.
• Authors: ANDERKOVÁ, Ľubomíra (703 Slovakia, belonging to the institution) and Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution).
• Edition: Journal of the neurological sciences, Netherlands, Amsterdam : Elsevier, 2014, 0022-510X.

Other information

• Original language: English
• Type of outcome: Article in a journal
• Field of Study: 30000 3. Medical and Health Sciences
• Country of publisher: United States of America
• Confidentiality degree: is not subject to a state or trade secret
• WWW: URL
• Impact factor: Impact factor: 2.474
• RIV identification code: RIV/00216224:14740/14:00075050
• Organization unit: Central European Institute of Technology
• Doi: http://dx.doi.org/10.1016/j.jns.2014.01.037
• UT WoS: 000335123500005
• Keywords in English: rTMS; Cognition; Alzheimer's disease; Parkinson's disease; MCI; Neurodegenerative; Systematic review
• Tags: kontrola MP, rivok
• Tags: International impact, Reviewed

Abstract

Repetitive transcranial magnetic stimulation (rTMS) represents a promising tool for studying and influencing cognition in people with neurodegenerative diseases. This procedure is noninvasive and painless, and it does not require the use of anesthesia or pharmacological substances. In this systematic critical review we report outcomes from research focused on behavioral cognitive effects induced by rTMS in patients with Alzheimer's disease (AD), Parkinson's disease (PD), and mild cognitive impairment (MCI) preceding AD. There are still major limitations to rTMS use, such as a poor understanding of its after-effects and inter-individual variability in their magnitude, discrepancies in stimulation protocols and study designs, varied selection of the specific stimulated areas and control procedures, and neuropsychological methods for assessment of after-effects; hence, the results of the present research can only be considered preliminary. The future directions are discussed.

Links

• ED1.1.00/02.0068, research and development project: Name: CEITEC - central european institute of technology
• NT13499, research and development project: Name: Řeč, její poruchy a kognitivní funkce u Parkinsonovy nemoci